Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday newspaper round-up: Twitter, M&S, TalkTalk

(Sharecast News) - Elon Musk has begun discussions with possible partners for a bid on Twitter after the iconic social media outfit put in place a so-called 'poison pill' in an attempt to thwart a mooted £33bn takeover. That stratagem was preceded by Twitter's rejection of an offer from Musk last Friday worth $54.20 a share. The pill would be activated should Musk take his own stake over the 15% threshold. - Sunday Times

In a blow to Marks & Spencer, BlackRock, the world's biggest asset manager, and hedge fund Marshall Wace, disclosed a combined £35m short position against the retailer's stock just weeks after it announced that the head of its food unit, Stuart Machin, would take over at the helm, alongside Katie Bickerstaffe. They were the first bets disclosed since December and together with recent share price falls revealed that the City was unconvinced about its prospects under new management. For Richard Hyman, a partner retail consultancy TPC, M&S had erred by focusing so much on food instead and not enough on food, which had higher margins. - Financial Mail on Sunday

Bankers believe that Vodafone is the frontrunner to come away with TalkTalk, the mobile firm that has put itself up for sale. Vodafone and Sky have also been reported as possible buyers of the firm, whose owners and managers are said to be pursuing a £3bn transaction price. Analysts at Enders however believe that price tag will not be reached without a bidding war. Vodafone however could bolster its broadband unit through a purchase and it would stand a better chance of obtaining the prerequisite green light from competition authorities. - The Financial Mail on Sunday

THG has suffered another blow with the exit of the founder of one of its leading beauty businesses with brands complaining of late payments. Alexia Inge, co-founder of Cult Beauty, which sold skincare, haircare and cosmetics brands, wrote to staff this month to announce her departure. THG acquired Cult Beauty for £275m in 2021. It joined THG's other brands, such as Lookfantastic and Myprotein. Yet both current and former employees told The Sunday Times that the company's culture had worsened since the purchase. One employee added that brands were not being paid as they used to be. The owner of a beauty brand said: "Cult Beauty used to be great at paying on time [60 days], but ever since the THG acquisition, we haven't been paid once." - The Sunday Times

Ministers have bowed to pressure from the likes of Google and Facebook and will soften a planned clampdown on the acquisition of technology companies under the Digital Markets Units due to concern that it might stifle investment in UK startups, Whitehall sources say. The unit had been set up under the Competition and Markets Authority in order to rein in Silicon Valley giants by allowing it greater leeway to intervene in takeovers by large tech firms with "strategic market status". - Sunday Telegraph

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.